Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542


Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

Evaluate Epi Analyzer

Evaluate Epi Analyzer provides unique insights on the commercial value of an indication as well as patient populations, bringing together Evaluateā€™s expertise in consensus forecasts with a highly granular epidemiology database.


Evaluate consensus forecasts integrated with Epi data in one user friendly platform for:

  • Disease Profiling
  • R&D Planning

  • Product Valuation and Portfolio Screening
  • Budget Impact and Health Economics Modelling

Build robust product valuations with detailed patient segmentation covering over 200 diseases and 8,000 sub-populations allowing you to measure the true value of a product.

Quantify patient populations for clinical trial design selecting disease and conditions across 54 countries.

Perform disease profiling with a customisable interface and data sets with details on biomarkers, co-morbidities, line of therapy, disability scales, and age coverage from 0 to 100 in 5 year increments.

Conduct budget impact analysis and health economics modelling, forecast future changes in patient populations and drivers and the impact on sales.

Evaluate Epi Analyzer is available as an add on module to EvaluatePharma.

For more information: Download brochure

Contact us today for a demo